QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

  On Friday morning, 60 companies achieved new highs for the year.

 the-daily-biotech-pulse-mesoblast-slumps-on-fda-rejection-astrazenecas-breakthrough-therapy-designation-3-ipos

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 51-biggest-movers-from-yesterday
51 Biggest Movers From Yesterday
10/02/2020 08:57:27

Gainers Solid Biosciences Inc. (NASDAQ: SLDB) shares climbed 70.4% to close at $3.46 on Thursday after the company announced...

 5-stocks-to-watch-for-october-2-2020

Some of the stocks that may grab investor focus today are:

 66-biggest-movers-from-yesterday
66 Biggest Movers From Yesterday
08/19/2020 09:14:43

Gainers

Core News & Articles

Gainers MICT Inc (NASDAQ: MICT) shares surged 96% to $6.86 after the company announced its subsidiary Micronet has received ...

 aduro-biotech-q2-eps-021-up-from-023-yoy-sales-557m-up-from-489m-yoy

Aduro Biotech (NASDAQ:ADRO) reported quarterly losses of $(0.21) per share. This is a 8.7 percent increase over losses of $(0.2...

 aduro-biotech-announces-first-patient-dosed-in-phase-1-study-of-bion-1301-in-iga-nephropathy

Aduro Biotech Announces First Patient Dosed in Phase 1 Study of BION-1301 in IgA Nephropathy BERKELEY, Calif., June 24, 2020 (...

Core News & Articles
72 Biggest Movers From Yesterday
06/03/2020 09:11:50

Gainers Precigen, Inc. (NASDAQ: PGEN) shares surged 83.3% to close at $3.96 on Tuesday.

Core News & Articles

Gainers Tenax Therapeutics Inc (NASDAQ: TENX) shares climbed 42.3% to $2.07 after the company reported results from its Phas...

 a-peek-into-aduro-biotechs-pe-ratio

 

Core News & Articles

Following the market opening Tuesday, the Dow traded up 0.67% to 25645.59 while the NASDAQ rose 0.07% to 9558.84. The S&P a...

 aduro-biotech-and-chinook-therapeutics-announce-definitive-merger-agreement

– Combined Company Will Operate as Chinook Therapeutics and Advance Pipeline of Clinical-Stage Programs in Kidney Diseases, Led...

 aduro-biotech-q1-eps-0090-up-from-0290-yoy-sales-13950m-up-from-3938m-yoy

Aduro Biotech (NASDAQ:ADRO) reported quarterly losses of $(0.090) per share. This is a 68.97 percent increase over losses of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION